Fibronectin expression during physiological and pathological cardiac growth

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Extracellular Matrix Research

Background:

• Fibronectin (FN) is a crucial extracellular matrix glycoprotein involved in cell adhesion, migration, and tissue repair.
• Alternative splicing of the FN gene generates diverse isoforms with distinct functions.
• Cardiac FN expression patterns are altered during development and in response to cardiac hypertrophy.

Purpose of the Study:

• To review and analyze the differential expression of fibronectin (FN) isoforms in the myocardium during various models of cardiac growth.
• To elucidate the role of FN isoform changes in response to developmental and pathological cardiac remodeling.

Main Methods:

• Qualitative and quantitative analyses of FN expression in rat myocardium.
• Examination of FN phenotypes in models of fetal development and pressure-overload-induced cardiac hypertrophy.
• Focus on differential expression of FN isoforms.

Main Results:

• Cardiac FN phenotype is developmentally regulated in the rat myocardium.
• Re-expression of fetal FN isoforms is observed in models of cardiac hypertrophy secondary to hypertension.
• Alterations in cardiac FN expression predominantly affect coronary artery smooth muscle cells.

Conclusions:

• Cardiac fibronectin expression is dynamically regulated during development and in response to hypertrophic stimuli.
• Fetal FN isoforms are re-expressed in the adult hypertrophied heart, suggesting a role in pathological remodeling.
• Coronary artery smooth muscle cells are a primary site of altered FN expression in cardiac growth models.